A solitary fibrous tumor (SFT) is a rare mesenchymal tumor. Ex situ hepatectomy and liver autotransplantation are novel methods for the treatment of complicated liver tumors, for example, those involving vascular structures, including the inferior vena cava, which are unresectable by conventional approaches. The present study describes a rare case of a massive hepatic SFT in a 32-year-old female who underwent ex situ hepatectomy and liver autotransplantation to achieve a radical resection. The surgery was without complications. Post-operative histopathological and immunohistochemical examinations revealed an SFT of the liver. The patient was discharged 29 days after the surgery with fully recovered liver function. The routine check-up 3 months after surgery indicated normal liver function and no evidence of recurrence. Additionally, an exhaustive review of available literature was performed to provide a complete overview of the current status of SFTs. In summary, the present study found that ex situ hepatectomy and liver autotransplantation are suitable surgical techniques for treating a giant SFT, as well as other liver neoplasms that are considered unresectable by conventional surgery.
Introduction
A solitary fibrous tumor (SFT) is a rare mesenchymal tumor, which can be found in different locations within the human body (1) . SFTs were first reported in the pleura and subsequently in the peritoneum, thymus, orbit, pericardium, meninges, spinal cord, and the parotid and thyroid glands (2) . A tumor of this type in the liver is an extremely rare occurrence. The majority of SFTs are considered benign, while <20% are reported to be malignant and are accompanied by tumor invasion and metastasis (3) . Surgical resection is the main approach for SFT treatment. Nevertheless, in certain cases where vascular structures are involved, conventional surgery may not be practical.
Ex situ hepatectomy and liver autotransplantation are novel methods for treating complicated liver tumors that are unresectable by conventional approaches, including liver transplantation, vascular reconstruction, organ perfusion, extended hepatic resection and hemodynamic management, which are considered to be some of the most complicated, difficult and risky types of surgeries. In this maneuver, the whole liver is removed and perfused with cold preservation solution. The tumor is resected ex situ on the operating table and the remaining liver is orthotopically implanted. The ex situ liver resection was first described by Pichlmayr et al (4) as a novel surgical procedure to treat a bilateral liver leiomyosarcoma. To date, only a few cases of ex situ hepatectomy and liver autotransplantation have been described worldwide (5, 6) . Furthermore, to the best of our knowledge, there are no reports on adopting ex situ hepatectomy and liver autotransplantation as an approach for treating hepatic SFTs. The present case study reports the first case of a giant SFT involving the inferior vena cava (IVC) of the liver in a 32-year-old female who was treated with ex situ hepatectomy and liver autotransplantation.
Case report
A 32-year-old female suffering from repeated abdominal distension for 3 years was found to have an oversized mass in the right hepatic lobe using a B-scan ultrasound, and was admitted on July 7, 2017 Dilation of the intrahepatic biliary ducts was also noted (Fig. 1) .
A CT arteriography scan showed that the mass was supplied with blood by the left and right hepatic arteries. The right, middle and left hepatic veins were compressed by the mass and there was indication of a filling defect in the IVC. A magnetic resonance imaging scan was also performed, revealing an oversized, heterogeneous liver mass (21.2x19.7 cm). A heterogeneous high signal in the T2-weighted image and a slightly low signal in the T1-weighted image were observed. All results indicated that the lesion was malignant and a mesenchymal tumor was suspected. In view of the young age of the patient, an ex situ hepatectomy and liver autotransplantation were performed on October 17, 2017. During the surgery, the second hepatic portal was difficult to expose and the sternum was therefore removed with the assistance of a cardiothoracic expert. An intra-operative frozen section examination indicated the proliferation of fibrotic tissue, and the tumor was considered to be benign. Consequently, the tumor was resected on the bench. A 26-mm artificial blood vessel was utilized to establish an end-to-side portocaval shunt during the anhepatic period and the liver remnant was autotransplanted in a piggyback fashion. The surgery was without complications and lasted for 18 h, with an anhepatic period of 5 h.
The resected specimen was well-delimited and measured 19.0x19.5x14.0 cm in size and 3.964 kg in weight. The tumor presented with a grayish-white interlaced appearance in the section plane, and was comprised of spindle-shaped cells infiltrated with lymphocytes, plasmocytes and mastocytes (Fig. 2) . The immunohistochemical (IHC) examination was performed on paraffin-embedded specimens fixed in 4% buffered neutral formalin at 37˚C for 24 h. Paraffin-embedded sections (3 µm) were deparaffinized and and endogenous peroxidase was inactivated with 15% H 2 O 2 -Methanol for 5 min at room temperature. The sections were then incubated with primary antibodies at 37˚C for 30 . The Ki-67 proliferative index was examined under a light microscope (BX53; Olympus Corporation, Tokyo, Japan), and was evaluated by experienced pathologists. A total of 500 tumor cells were counted both at the center and at the periphery of the tumor. The examination was repeated at least twice and the mean Ki-67 proliferative index was calculated. At least 10 mm of the margins of the resected specimen were tumor-free. Based on the pathological and IHC characteristics, the lesion was identified as an SFT.
On post-operative day 9, the patient underwent pleurocentesis and received drainage tubes due to moderate right pleural effusion, which were successfully removed 16 days later. The patient recovered fully and was discharged on post-operative day 29. At the 1-and 3-month follow-ups, the patient had normal liver function and there was no evidence of recurrence. Future follow-up will be performed every 6 months.
Discussion
SFTs are mesenchymal neoplasms that typically occur in the thoracic or pleural cavities. The SFTs found in the liver may derive from the intra-hepatic connective tissue, for example Glisson's capsule or conjunctive tissue, which are rare types of liver neoplasm (7) . A search of the English literature on 'Solitary Fibrous Tumour of the Liver' was conducted on PubMed (https://www.ncbi.nlm.nih.gov/pubmed/) and Google (https://www.google.com/). All published English articles, case reports and literature reviews, and their reference lists, were reviewed. The results indicated that only 88 cases of SFTs of the liver have been reported since 1958 . The main characteristics of these cases are listed in Table I . The mean age of onset was 57.1 years (range, 16.0-87.0 years) and the lesion appeared more commonly in female patients (ratio 1.4:1), with a mean tumor diameter of 18.2 cm (range, 1.5-30.0 cm). The median follow-up time for these cases was 13.5 months. The prolonged course and biological features of SFTs resulted in a relatively late age of onset and large lesion size. The patient in the present study was a 32-year-old female with a single lesion measuring ~19.0 cm; these characteristics were consistent with the cases listed in Table I .
Due to the lack of overt or specific symptoms, patients with SFTs are usually diagnosed coincidentally during a check-up or at a late stage when masses are large enough to produce discomfort by invading or compressing adjacent structures. In the present case, the patient had complained of repeated abdominal distension for 3 years due to the compression of neighboring structures by the lesion. With the exception of the presence of non-islet cell tumor hypoglycemia syndrome observed in 13 cases (9, 16, 17, 19, 22, 25, 28, 31, 36, 48, 60, 69, 70) , the results of laboratory tests for routine biochemical parameters, including aminotransferases or tumor markers, appear normal or slightly, non-specifically altered (33) , as was the case with the present patient. Although imaging tests can provide physical characteristics of lesions for clinical analysis, including location and size, the radiological features of an SFT lack specificity, suggesting that none of the aforementioned tests are conclusive.
The gold standard for diagnosing an SFT remains as histopathological analysis combined with IHC examination. Fine-needle aspiration cytology (FNAC) is commonly performed to acquire lesion tissue for pathological diagnosis prior to surgery. Nevertheless, FNAC may be misleading or inconclusive pertaining to the diagnosis of an SFT (37) . Percutaneous liver biopsy may not provide the definitive diagnosis, while increasing the risk of tumor growth and implantation (53) . Histopathological findings in the present case were typical for an SFT: Diffusive proliferation of spindle-shaped mesenchymal cells with oval-fusiform nuclei along with fibrocollagenous stroma; no prominent cellular atypia, infiltrative margins or other indicative evidence of malignancy; and tumor cells of all reported cases with an SFT, including the present case, were positive for CD34, which may differentiate an SFT from other spindle cell neoplasms (12) . CD99, B-cell lymphoma 2 or vimentin have also shown to be positive in almost half the cases (14-19-21,24-27,29-33,36-48,50,52-71).
Radical surgical resection is the main treatment approach. Among the reported cases listed in Table I , 85.2% (75/88) patients received radical surgical resection and on average had ≥3 segments removed owing to the size of the SFTs. Other treatments, such as chemotherapy, which was adopted recently in two patients listed in Table I , resulted in only 4-5 months survival following treatment. Therefore, Makino et al (67) suggested that due to the unclear effects of other treatments, including chemotherapy and radiotherapy, hepatic resection with clear margins is highly recommended in patients with large SFTs, considering the risk of urgent symptoms and the potential for malignancy. Compared with the previously reported cases, the tumor reported in the present study was difficult to resect using the conventional approach due to the advanced extent of the lesion therefore, novel techniques may be required.
Even with the vast improvement of surgical techniques, hepatic lesions abutting hepatic veins or the confluence of the IVC, as well as large centrally located lesions, fail to be managed by conventional surgery. In such cases, liver transplantation may be indicated (26) . However, no liver trans-26). However, no liver trans-). However, no liver transplantations have been performed to date for treating SFTs. In the present case, the second hepatic portal was compressed by the neoplasm, causing obstruction of the outflow tract and liver congestion. Full exposure of the second hepatic portal was achieved only after the sternum was removed. The vascular reconstruction and extended hepatic resection were extremely difficult to achieve by in situ surgical resection. Given the young age of the patient, the alternative of ex situ hepatectomy and liver autotransplantation was implemented. The surgery was performed successfully and the patient recovered without further complications. To the best of our knowledge, this is the first case report describing the adoption of ex situ hepatectomy and liver autotransplantation to treat a liver SFT, otherwise unresectable by standard surgery. The ex situ hepatectomy and liver autotransplantation was initially performed by Pichlmayr et al (4) in 1988 for treating liver tumors involving major vascular structures. The procedure has progressed and developed over the past 30 years, and has been successfully applied for the treatment of several types of lesions, including hepatocellular carcinoma (72, 73) , hilar cholangiocarcinoma (74), giant hepatic hemangiomas (75) and metastatic colon cancer (72, 73, 76) . The reported cases are listed in Table II . The median follow-up and survival times for these cases were 13 and liver and renal failure 25 months, respectively. In addition, 63.6% (28/44) patients receiving ex situ hepatectomy and liver autotransplantation were <55 years old, as was the patient reported in the present case. The common indications for this method are major vein involvement and extensive resection area, both of which were noted in the present case. Compared with conventional liver resection, ex situ hepatectomy and liver autotransplantation markedly improve the rate of successful resection and clear margins of the otherwise unresectable lesions. There is no long waiting time for a suitable allograft, as an autologous liver is implanted. In addition, the total cost is lower and no post-operative immunosuppressants are required for patients receiving ex situ hepatectomy and liver autotransplantation, compared with an allograft liver transplantation (5) . The successful establishment of venous reflux and hypothermic perfusion of the isolated liver are essential for securing a successful surgery and a good prognosis (77) . As the liver resection and trimming surgery are time-consuming, the prolonged anhepatic phase can lead to hemodynamic or internal environmental disturbances. Therefore, in the present case, an artificial blood vessel was used to establish an end-to-side portocaval shunt in order to maintain the venous return of the intestinal tract and lower limbs during the anhepatic period. Compared with autologous vessels, including the great saphenous vein, use of an artificial blood vessel minimizes the invasiveness of the procedure for the patient. As the shunt is temporary, the potential tissue rejection is of no concern.
The commonly encountered complications of ex situ hepatectomy and liver autotransplantation include bile leakage, bleeding, pulmonary infection, pneumonedema, hydrothorax and renal insufficiency, with a total incidence of 58.1%. The overall mortality rate within 90 days after surgery is 19.5% (5) . In the present study, the patient presented with moderate right pleural effusion following surgery, and recovered fully following pleurocentesis and drainage. No other severe complications were encountered up to 3 months after surgery.
In conclusion, this is the first report that describes the successful adoption of ex situ hepatectomy and liver autotransplantation for treating an otherwise unresectable giant SFT. The uneventful surgical course and post-operative period suggested that this procedure was suitable for managing an unresectable liver neoplasm. Furthermore, the artificial blood vessels may provide a reliable source for establishing an end-to-side portocaval shunt during the anhepatic period.
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